OMERS Administration Corp
JSPR icon

OMERS Administration Corp’s Jasper Therapeutics JSPR Stock Holding History

OMERS Administration Corp’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,260
Closed -$225K – 450
2021
Q2 		$225K Hold
2,260
– – ﹤0.01% 285
2021
Q1 		$225K Sell
2,260
-2,739
-55% -$279K ﹤0.01% 296
2020
Q4 		$500K Buy
+4,999
New +$497K 0.01% 180

Other funds holding JSPR

A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPARFS
Leverage Partners Absolute Return Fund SPC Cayman Islands Ky1-11111, Cayman Islands $54M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

OMERS Administration Corp's JSPR Position: Q3 2021 in Review

OMERS Administration Corp sold out of Jasper Therapeutics (JSPR) in Q3 2021, closing a stake of 2,260 shares — an estimated $225K sold.

OMERS Administration Corp first reported a position in JSPR in Q4 2020 and held it in 3 quarters. The position peaked at $500K in Q4 2020. 10 funds tracked by Wall St. Rank hold JSPR as of Q3 2021.

  • OMERS Administration Corp reported no remaining Jasper Therapeutics position as of Q3 2021 after selling out during the quarter.
  • OMERS Administration Corp sold 2,260 Jasper Therapeutics shares in Q3 2021, an estimated $225K.
  • OMERS Administration Corp first reported a position in Jasper Therapeutics in Q4 2020 and held it in 3 quarters.
  • OMERS Administration Corp's Jasper Therapeutics position peaked at $500K in Q4 2020.
  • 10 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q3 2021.

Based on OMERS Administration Corp's 13F filing for Q3 2021, filed 12 Nov 2021.